ArticleThoracic cancer2021

Comparing survival and treatment response of patients with acquired T790M mutation second-line osimertinib versus sequential treatment of chemotherapy followed by osimertinib: A real-world study.

Chin-Chou Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.